CIDP (chronic inflammatory demyelinating polyneuropathy) trials in Romania
7 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study to Evaluate the Pharmacokinetics and Safety of XEMBIFY Versus Gamunex-C in Participants With Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Where
- Târgu Mureş
- Age
- 18 years and over
- People
- 40 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to joinNCT07540221 - Phase 3Taking peopleA Study to Assess the Efficacy and Safety of Empasiprubart in Adults With CIDP
- Where
- Brasov, Bucharest, Campulung, Deva
- Age
- 18 years and over
- People
- 160 worldwide
- Run by
- argenx
See details and how to joinNCT07091630 · EU 2025-520805-10-00 - Phase 3Taking peopleA Study to Assess Efficacy and Safety of Empasiprubart Versus IVIg in Adults With CIDP
- Where
- Bucharest, Constanta, Târgu Mureş
- Age
- 18 years and over
- People
- 218 worldwide
- Run by
- argenx
See details and how to joinNCT06920004 · EU 2024-520097-36-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Bucharest, Târgu Mureş
- Age
- 18 years to 75 years
- People
- 256 worldwide
- Run by
- Dianthus Therapeutics
See details and how to joinNCT06858579 - Phase 3Taking peopleA Phase III study to evaluate how the body processes Xembify in comparison to Gamunex-C and determine the safety and in people with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
- Where
- Bucharest, Târgu Mureş
- Age
- 18 years and over
- People
- 20 worldwide
- Run by
- Grifols Therapeutics LLC
See details and how to join2025-522165-30-00 · EU 2025-522165-30-00 - Phase 2Taking peopleImeroprubart in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Where
- Constanta
- Age
- 18 years and over
- People
- 162 worldwide
- Run by
- Immunovant Sciences GmbH
See details and how to joinNCT07032662 · EU 2024-517614-14-00 - Phase 3Taking peopleA Study to Evaluate the Efficacy and Safety of DNTH103 in Adults with Chronic Inflammatory Demyelinating Polyneuropathy (CAPTIVATE)
- Where
- Bucharest, Constanta, Târgu Mureş, Timisoara
- Age
- 18 years and over
- People
- 138 worldwide
- Run by
- Dianthus Therapeutics Inc.
See details and how to join2024-517529-26-00 · EU 2024-517529-26-00